Lack of Clinical Usefulness of Das-1 Monoclonal Antibody and Mucin Expression as Risk Markers of Gastric Carcinoma in Patients With Gastric Intestinal Metaplasia-Reference-Cited by-同舟云学术

Lack of Clinical Usefulness of Das-1 Monoclonal Antibody and Mucin Expression as Risk Markers of Gastric Carcinoma in Patients With Gastric Intestinal Metaplasia

Published:2009-01-01 Issue:1 Volume:131 Page:99-105
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Forné Montserrat¹,Fernández-Bañares Fernando¹,González-Mínguez Clarisa²,Casalots Jaume²,Poblet-Mas Núria³,Garcia-Gil L. Jesús³,Esteve Maria¹,Rosinach Mercè¹,Espinós Jorge¹,Loras Carme¹,Salas Antonio²,Viver Josep M.¹

Affiliation:

1. Departments of Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Spain

2. Pathology, Hospital Universitari Mútua Terrassa, Terrassa, Spain

3. Laboratory of Molecular Microbiology, Department of Biology, University of Girona, Girona, Spain

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/131/1/99/24986941/ajcpath131-0099.pdf

Reference24 articles.

1. Precancerous conditions and epithelial dysplasia in the stomach;Morson;J Clin Pathol,1980